# FDA Inspection 1058071 - Vitalant - June 15, 2018

Source: https://www.keypedia.com/records/fda_inspections/vitalant/16a4c458-51b6-4d3b-8cb7-91e1e35f0b52
Source feed: FDA_Inspections

> FDA Inspection 1058071 for Vitalant on June 15, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1058071
- Company Name: Vitalant
- Inspection Date: 2018-06-15
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1175785 - 2022-07-21](https://www.keypedia.com/records/fda_inspections/vitalant/8b7635c3-84c8-476b-b37a-96438810a6a0)
- [FDA Inspection 1175785 - 2022-07-21](https://www.keypedia.com/records/fda_inspections/vitalant/61938d27-f331-4482-bf5d-fdfdfdc624e0)
- [FDA Inspection 982339 - 2016-08-10](https://www.keypedia.com/records/fda_inspections/vitalant/0f86def8-da90-4a22-811a-420c63e979a6)
- [FDA Inspection 808650 - 2012-11-09](https://www.keypedia.com/records/fda_inspections/vitalant/15a59f08-2876-420b-9c5f-6cd7bc8eedf9)
- [FDA Inspection 702149 - 2010-12-10](https://www.keypedia.com/records/fda_inspections/vitalant/5b72a32b-2586-4544-95aa-b21ef84d2659)

Company: https://www.keypedia.com/companies/vitalant/aa6b00a8-2b64-4251-b14f-8b255d8b9408

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d